IFNAR1 and infection: Overall, infection in mice receiving 1 mg of anti-IFNAR1 mAb 48 h before the infection was more severe (66% mortality, 83% severe disease) compared to those receiving the same dose of mAb 24 h before infection (50% mortality and severe disease) (Figure 1(b,c)).